Syngen Biotech Co.,Ltd. (TPEX:8279)
Taiwan
· Delayed Price · Currency is TWD 98.60
-1.40 (-1.40%)
Apr 29, 2026, 1:30 PM CST
Syngen Biotech Revenue
Syngen Biotech had revenue of 416.66M TWD in the quarter ending March 31, 2026, a decrease of -14.25%. This brings the company's revenue in the last twelve months to 2.07B, up 1.74% year-over-year. In the year 2025, Syngen Biotech had annual revenue of 2.14B with 6.10% growth.
Revenue (ttm)
2.07B
Revenue Growth
+1.74%
P/S Ratio
1.31
Revenue / Employee
8.37M
Employees
247
Market Cap
2.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.14B | 122.89M | 6.10% |
| Dec 31, 2024 | 2.01B | 176.41M | 9.60% |
| Dec 31, 2023 | 1.84B | -93.41M | -4.84% |
| Dec 31, 2022 | 1.93B | 459.33M | 31.22% |
| Dec 31, 2021 | 1.47B | 159.83M | 12.19% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| 3D Global Biotech | 206.74M |
| Apex Biotechnology | 1.94B |
| HeXun Biosciences | 293.23M |
| BRIM Biotechnology | 5.49M |
| SYN-TECH Chem. & Pharm. | 1.30B |
| Sinew Pharma | 47.00K |
| GlycoNex Incorporation | 37.86M |
| Shine-On BioMedical | 30.00M |